Clinically Resectable Acinar Cell Carcinoma of the Pancreas: Is There a Benefit to Adjuvant Systemic Therapy?

ConclusionsAdjuvant therapy is associated with a significant survival benefit in patients with resectable acinar cell carcinoma.
Source: The American Journal of Surgery - Category: Surgery Source Type: research